Literature DB >> 6194182

Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.

A K Ghosh, D Y Mason, A I Spriggs.   

Abstract

In order to assess the practical value of immunocytochemical techniques in routine cytological diagnosis, a panel of three monoclonal antibodies (anti-CEA, Ca 1 and HMFG-2) were used to search for malignant cells in 53 samples of pleural or peritoneal fluid from 41 selected patients. All these patients suffered from malignant disease, but neoplastic cells had not been reported on conventional cytological examination. In 12 of the 41 cases immunocytochemical staining revealed previously unrecognised malignant cells. This represents an increase in diagnostic accuracy of approximately 20% and suggests that immunocytochemical labelling should be used routinely for the examination of cytologically negative samples from patients with suspected malignant disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194182      PMCID: PMC498493          DOI: 10.1136/jcp.36.10.1150

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Experience with the Oxford tumour marker (Ca1) in serous fluids.

Authors:  G Pallesen; F L Jepsen; J Hastrup; A Ipsen; N Hvidberg
Journal:  Lancet       Date:  1983-06-11       Impact factor: 79.321

2.  Evaluation of Cal antibody in pleural biopsy material.

Authors:  R A Burnett; A R Deery; M R Adamson; C Liddle; M Thomas; G H Roberts
Journal:  Lancet       Date:  1983-05-21       Impact factor: 79.321

3.  A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca1 antibody.

Authors:  J C Woods; A I Spriggs; H Harris; J O McGee
Journal:  Lancet       Date:  1982-09-04       Impact factor: 79.321

4.  Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies.

Authors:  A K Ghosh; A I Spriggs; J Taylor-Papadimitriou; D Y Mason
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

5.  Use of monoclonal antibodies for the histopathological diagnosis of human malignancy.

Authors:  K C Gatter; Z Abdulaziz; P Beverley; J R Corvalan; C Ford; E B Lane; M Mota; J R Nash; K Pulford; H Stein; J Taylor-Papadimitriou; C Woodhouse; D Y Mason
Journal:  J Clin Pathol       Date:  1982-11       Impact factor: 3.411

6.  Epithelial Membrane Antigen. Its use in the cytodiagnosis of malignancy in serous effusions.

Authors:  A To; D P Dearnaley; M G Ormerod; G Canti; D V Coleman
Journal:  Am J Clin Pathol       Date:  1982-08       Impact factor: 2.493

7.  A new marker for human cancer cells. 1 The Ca antigen and the Ca1 antibody.

Authors:  F Ashall; M E Bramwell; H Harris
Journal:  Lancet       Date:  1982-07-03       Impact factor: 79.321

8.  A new marker for human cancer cells, 2 immunohistochemical detection of the Ca antigen in human tissues with the Ca1 antibody.

Authors:  J O McGee; J C Woods; F Ashall; M E Bramwell; H Harris
Journal:  Lancet       Date:  1982-07-03       Impact factor: 79.321

9.  Immunoperoxidase demonstration of carcinoembryonic antigen in pleural and peritoneal effusions.

Authors:  M Sehested; E Ralfkjaer; J Rasmussen
Journal:  Acta Cytol       Date:  1983 Mar-Apr       Impact factor: 2.319

  9 in total
  10 in total

1.  Evaluation of impact of immunocytochemical techniques in cytological diagnosis of neoplastic effusions.

Authors:  A Linari; G Bussolati
Journal:  J Clin Pathol       Date:  1989-11       Impact factor: 3.411

2.  Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.

Authors:  G Schlimok; I Funke; B Holzmann; G Göttlinger; G Schmidt; H Häuser; S Swierkot; H H Warnecke; B Schneider; H Koprowski; G Riethmüller
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Use of immunocytochemical staining to identify cells in peritoneal fluid and washings at laparoscopy and laparotomy.

Authors:  A K Ghosh; A I Spriggs; M Charnock
Journal:  J Clin Pathol       Date:  1986-12       Impact factor: 3.411

4.  The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3).

Authors:  C A Szpak; W W Johnston; V Roggli; J Kolbeck; S C Lottich; R Vollmer; A Thor; J Schlom
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

5.  Measurement of placental alkaline phosphatase activity in benign and malignant pleural effusions.

Authors:  R J Fergusson; J Fisken; M A McIntyre; J E Roulston; R C Leonard
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

6.  [Prospective comparison of the diagnostic value of cytology and immunocytology in pleural effusion studied by thoracoscopy and biopsy].

Authors:  A Neubauer; U Thalmann; R Musch; H Grosser; R Loddenkemper; D Huhn
Journal:  Klin Wochenschr       Date:  1987-05-04

7.  The search for tumor-associated proteins in pleural effusions by means of monoclonal antibodies and a dot blot assay.

Authors:  M Lawniczak; J Sikora; P Kania; J Zeromski
Journal:  Lung       Date:  1992       Impact factor: 2.584

8.  Immunocytochemical reaction of Ca1 and HMFG2 monoclonal antibodies with cells from serous effusions.

Authors:  S Singer; M M Boddington; E A Hudson
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

9.  Tissue biopsy of the lung: clinical applications.

Authors:  D J Lane
Journal:  J R Coll Physicians Lond       Date:  1985-07

10.  The immunocytochemical detection of axillary micrometastases in breast cancer.

Authors:  C A Wells; A Heryet; J Brochier; K C Gatter; D Y Mason
Journal:  Br J Cancer       Date:  1984-08       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.